Each year the World Health Organization (WHO) puts forward its recommendations for the composition of influenza virus for use in the Southern Hemisphere's influenza season. On the 6th of October ,the Australian Influenza Vaccine Committee (AIVC) confirmed their recommendation inline with the WHO recommendations.
The 2022 southern hemisphere influenza season vaccine contained the following:
Egg-based quadrivalent influenza vaccines( AVS Standard offer for 2022 flu season):
- an A/Victoria/2570/2019 (H1N1)pdm09-like virus
- an A/Darwin/9/2021 (H3N2)-like virus
- a B/Austria/1359417/2021-like (B/Victoria lineage) virus
- a B/Phuket/3073/2013-like (B/Yamagata lineage) virus